Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Understanding these guidelines matters because improper handling can compromise the therapy's intended action, and patients deserve clear, evidence-based information to protect their investment in treatment and maintain accountability with their provider
For the best results, it should be part of a broader, well-balanced approach that includes healthy lifestyle habits
For weight management, NICE has approved specific GLP-1 agonists (semaglutide [Wegovy] in TA875 and liraglutide [Saxenda] in TA664) as part of specialist weight management services
In a study participants who were treated with semaglutide (the active ingredient in Wegovy) reported a significant reduction in appetite, which contributed to an average weight loss of 14.9% of body weight over 68 weeks
US$ 21.60
US$ 26.98
US$ 25.14
US$ 24.81
US$ 26.18
